Krum H - Search Results

1

Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study.

Chin KL, Collier TJ, Pitt B, McMurray JJ, Swedberg K, van Veldhuisen DJ, Pocock SJ, Vincent J, Turgonyi E, Zannad F, Krum H; EMPHASIS-HF Study Investigators. Chin KL, et al. Among authors: krum h. Eur J Heart Fail. 2016 Sep;18(9):1175-81. doi: 10.1002/ejhf.485. Epub 2016 Feb 2. Eur J Heart Fail. 2016. PMID: 26833642 Free article.

2

Diagnostic and therapeutic potential of the endothelin system in patients with chronic heart failure.

Krum H, Denver R, Tzanidis A, Martin P. Krum H, et al. Heart Fail Rev. 2001 Dec;6(4):341-52. doi: 10.1023/a:1011416611765. Heart Fail Rev. 2001. PMID: 11447309 Review.

3

Improved outcomes from a comprehensive management system for heart failure.

Holst DP, Kaye D, Richardson M, Krum H, Prior D, Aggarwal A, Wolfe R, Bergin P. Holst DP, et al. Among authors: krum h. Eur J Heart Fail. 2001 Oct;3(5):619-25. doi: 10.1016/s1388-9842(01)00164-7. Eur J Heart Fail. 2001. PMID: 11595611 Free article.

4

Should patients with chronic heart failure be treated with "statins"?

Ashton E, Liew D, Krum H. Ashton E, et al. Among authors: krum h. Heart Fail Monit. 2003;3(3):82-6. Heart Fail Monit. 2003. PMID: 12634877 Review.

5

Eplerenone. Pharmacia.

Liew D, Martin J, Krum H. Liew D, et al. Among authors: krum h. Curr Opin Investig Drugs. 2003 Mar;4(3):316-22. Curr Opin Investig Drugs. 2003. PMID: 12744223 Review.

6

Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.

Haas SJ, Vos T, Gilbert RE, Krum H. Haas SJ, et al. Among authors: krum h. Am Heart J. 2003 Nov;146(5):848-53. doi: 10.1016/S0002-8703(03)00403-4. Am Heart J. 2003. PMID: 14597934 Review.

7

Eplerenone in the treatment of chronic heart failure.

Krum H, Liew D. Krum H, et al. Expert Rev Cardiovasc Ther. 2004 May;2(3):315-20. doi: 10.1586/14779072.2.3.315. Expert Rev Cardiovasc Ther. 2004. PMID: 15151479 Review.

8

Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT.

Krum H, Carson P, Farsang C, Maggioni AP, Glazer RD, Aknay N, Chiang YT, Cohn JN. Krum H, et al. Eur J Heart Fail. 2004 Dec;6(7):937-45. doi: 10.1016/j.ejheart.2004.09.005. Eur J Heart Fail. 2004. PMID: 15556056 Free article. Clinical Trial.

9

Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of >12,000 patients in large-scale clinical trials.

Dulin BR, Haas SJ, Abraham WT, Krum H. Dulin BR, et al. Among authors: krum h. Am J Cardiol. 2005 Apr 1;95(7):896-8. doi: 10.1016/j.amjcard.2004.11.052. Am J Cardiol. 2005. PMID: 15781028

10

Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.

Krum H, Haas SJ, Eichhorn E, Ghali J, Gilbert E, Lechat P, Packer M, Roecker E, Verkenne P, Wedel H, Wikstrand J. Krum H, et al. Eur Heart J. 2005 Oct;26(20):2154-8. doi: 10.1093/eurheartj/ehi409. Epub 2005 Jul 13. Eur Heart J. 2005. PMID: 16014644 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

591 results

Search Page

Filters